MondegarAI
Blue Owl Capital Holdings LP

Q4 2024 · 13F-HR

Blue Owl Capital Holdings LPholdings as filed

Filed 2025-02-14 · accession 0000950123-25-002412

$434.0M
Reported value
78
Positions
2024-12-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
67090S108NCDLNUVEEN CHURCHILL DIRECT LEND$67.8M15.6%4,039,553CommonSOLE
49845K101KVYOKLAVIYO INC$44.5M10.3%1,078,770CommonSOLE
729139105PLRXPLIANT THERAPEUTICS INC$36.5M8.40%2,769,199CommonSOLE
69121K104OBDCBLUE OWL CAPITAL CORPORATION$30.9M7.12%2,045,070CommonSOLE
230031106CGEMCULLINAN THERAPEUTICS INC$28.9M6.65%2,370,972CommonSOLE
206787103CNDTCONDUENT INC$22.7M5.24%5,625,459CommonSOLE
89157D105TRMLTOURMALINE BIO INC$21.9M5.04%1,079,321CommonSOLE
29286M105ENGENE HOLDINGS INC$21.0M4.84%3,159,975CommonSOLE
29977X105EVCMEVERCOMMERCE INC$18.1M4.17%1,641,929CommonSOLE
517125100LRMRLARIMAR THERAPEUTICS INC$18.0M4.15%4,653,040CommonSOLE
38046W204GOCOGOHEALTH INC$11.1M2.57%83,264CommonSOLE
43538H103HLLYHOLLEY INC$9.0M2.08%2,990,294CommonSOLE
00445A100ACELYRIN INC$8.7M2.01%2,783,946CommonSOLE
28617K101ELDNELEDON PHARMACEUTICALS INC$8.1M1.86%1,959,912CommonSOLE
254604101IRONDISC MEDICINE INC$7.6M1.76%120,260CommonSOLE
45175G108IKENA ONCOLOGY INC$6.7M1.55%4,091,118CommonSOLE
21077P108CNTXCONTEXT THERAPEUTICS INC$6.7M1.54%6,357,928CommonSOLE
786700104SGMTSAGIMET BIOSCIENCES INC$6.0M1.37%1,323,877CommonSOLE
87583X109TNGXTANGO THERAPEUTICS INC$5.4M1.23%1,732,152CommonSOLE
90400D108RAREULTRAGENYX PHARMACEUTICAL IN$5.0M1.15%118,238CommonSOLE
30233G209EYPTEYEPOINT PHARMACEUTICALS INC$5.0M1.15%667,594CommonSOLE
760273102RPTXREPARE THERAPEUTICS INC$4.5M1.04%3,443,659CommonSOLE
29788T103ETWOGBPE2OPEN PARENT HOLDINGS INC$4.4M1.01%1,650,943CommonSOLE
20454B104CMPXCOMPASS THERAPEUTICS INC$4.3M0.99%2,954,712CommonSOLE
492327101KROSKEROS THERAPEUTICS INC$3.8M0.88%242,633CommonSOLE
152309100CNTACENTESSA PHARMACEUTICALS PLC$3.7M0.85%220,000CommonSOLE
03843E104AQSTAQUESTIVE THERAPEUTICS INC$3.2M0.74%900,000CommonSOLE
697947109PVLAPALVELLA THERAPEUTICS INC NE$3.0M0.69%250,062CommonSOLE
45790W108INOZYME PHARMA INC$3.0M0.69%1,080,027CommonSOLE
589492107MREOMEREO BIOPHARMA GROUP PLC$2.4M0.54%672,809CommonSOLE
57055L206MRKRMARKER THERAPEUTICS INC$1.7M0.40%554,250CommonSOLE
00791X100AEON BIOPHARMA INC$1.6M0.38%3,049,361CommonSOLE
H0036K147ADCTADC THERAPEUTICS SA$1.5M0.34%733,568CommonSOLE
293792107EPDENTERPRISE PRODS PARTNERS L$981,2540.23%31,290CommonSOLE
68217N105OMEGA THERAPEUTICS INC$787,2660.18%1,055,882CommonSOLE
824430102SHF HOLDINGS INC$683,0660.16%1,517,924CommonSOLE
G75398100RZLVREZOLVE AI LTD$669,8130.15%181,667CommonSOLE
56608A105MARBLEGATE ACQUISITION CORP$638,2320.15%91,429CommonSOLE
20451W101CMPSCOMPASS PATHWAYS PLC$609,4800.14%161,238CommonSOLE
37637K108GTLBGITLAB INC$567,7820.13%10,076CommonSOLE
G76279101ROIVROIVANT SCIENCES LTD$461,4050.11%39,003CommonSOLE
G75398118RZLVWREZOLVE AI LTD$446,5370.10%603,429CommonSOLE
G63290103PLMWFPLUM ACQUISITION CORP III$220,0000.05%1,166,665CommonSOLE
84445C118SLND/WSSOUTHLAND HLDGS INC$206,4720.05%860,302CommonSOLE
14149Y108CAHCARDINAL HEALTH INC$203,1880.05%1,718CommonSOLE
87169M105OPTXSYNTEC OPTICS HLDGS INC$124,9290.03%49,575CommonSOLE
020952115AMODWALPHA MODUS HLDGS INC$95,0400.02%1,187,999CommonSOLE
G63290129PLMUFPLUM ACQUISITION CORP III$94,5730.02%15,000CommonSOLE
87169M113OPTXWSYNTEC OPTICS HLDGS INC$88,3450.02%803,132CommonSOLE
M82363124SATIXFY COMMUNICATIONS LTD$77,7150.02%50,794CommonSOLE
654484153NIOBWNIOCORP DEVS LTD$68,9870.02%766,527CommonSOLE
G4411J106PITWFHERAMBA ELEC PLC$53,1630.01%989,998CommonSOLE
09263B116BKSY/WSBLACKSKY TECHNOLOGY INC$38,5000.01%350,000CommonSOLE
G7606H116RDZNWROADZEN INC$33,7500.01%225,000CommonSOLE
29286M113ENGENE HOLDINGS INC$30,4430.01%36,100CommonSOLE
09174P105BITCOIN DEPOT INC$25,7180.01%18,125CommonSOLE
G0705H111BDMDWBAIRD MED INVT HLDGS LTD$25,0000.01%100,000CommonSOLE
98944F117ZEOWWZEO ENERGY CORP$25,0000.01%250,000CommonSOLE
124420118BYNOWBYNORDIC ACQUISITION CORP$20,6470.00%516,185CommonSOLE
53838J113LVWR/WSLIVEWIRE GROUP INC$20,0000.00%400,000CommonSOLE
56608A113MARBLEGATE ACQUISITION CORP$17,9200.00%597,333CommonSOLE
Q9379E113VSTWFVAST RENEWABLES LIMITED$16,0000.00%200,000CommonSOLE
G50716110NVNIWNVNI GROUP LIMITED$14,0000.00%200,000CommonSOLE
G9889X115ZAPWFZAPP ELEC VEHS GROUP LTD$10,8030.00%1,930,986CommonSOLE
88165K119TVGNWTEVOGEN BIO HLDGS INC$10,0000.00%200,000CommonSOLE
G9503X111WALDWWALDENCAST PLC$5,6670.00%33,333CommonSOLE
45784G119ZCARWZOOMCAR HLDGS INC$5,0000.00%250,000CommonSOLE
23834J110DAVEWDAVE INC$4,6000.00%28,750CommonSOLE
854936119SDSTWSTARDUST PWR INC$4,5000.00%16,666CommonSOLE
485859110KPLTWKATAPULT HOLDINGS INC$4,0000.00%400,000CommonSOLE
09174P113BTMWWBITCOIN DEPOT INC$3,0000.00%50,000CommonSOLE
65488A119NKGNWNKGEN BIOTECH INC$3,0000.00%30,000CommonSOLE
M7S64L107PGYWWPAGAYA TECHNOLOGIES LTD$2,9200.00%48,661CommonSOLE
G7207P129ASBPWPOWERUP ACQUISITION CORP$2,5000.00%50,000CommonSOLE
71902K113CEROWCERO THERAPEUTICS HLDGS INC$2,2490.00%224,930CommonSOLE
104932116BNAIWBRAND ENGAGEMENT NETWORK INC$2,0580.00%34,303CommonSOLE
98400V119XBPEWXBP EUROPE HOLDINGS INC$9910.00%24,778CommonSOLE
124420100BYNOBYNORDIC ACQUISITION CORP$5490.00%91,429CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.